Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
1.670
+0.260 (18.44%)
Dec 20, 2024, 4:00 PM EST - Market closed
Tenaya Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Tenaya Therapeutics stock have an average target of 17.33, with a low estimate of 16 and a high estimate of 18. The average target predicts an increase of 937.72% from the current stock price of 1.67.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TNYA stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $18 | Strong Buy | Maintains | $18 | +977.84% | Dec 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +977.84% | Dec 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +977.84% | Nov 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +977.84% | Nov 25, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +977.84% | Nov 7, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
3.35M
EPS This Year
-1.38
from -1.68
EPS Next Year
-1.27
from -1.38
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | 15.8M | 73.6M | |||
| Avg | n/a | 3.4M | 22.2M | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 2,096.5% | |||
| Avg | - | - | 561.5% | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.38 | -0.96 | -0.71 | |||
| Avg | -1.38 | -1.27 | -1.30 | |||
| Low | -1.36 | -1.39 | -1.55 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.